Global Patient Recruitment and Retention Services Market

Report ID : 1335 | Published : 2022-07-20 | Pages: | Format: PDF/EXCEL

The market size of the Global Patient Recruitment and Retention Services Market in the year 2021 is valued at 3.63 billion and is predicted to reach 5.45 billion by the year 2030 at an 4.7% CAGR during the projected period.

Patient recruitment and retention is an essential service for the clinical research industry, and certain developments are expected to play a significant role in the future. Patient recruitment is one of the rate-limiting stages in bringing medications to market. In addition, given the typical clinical research dropout rate, keeping patients on board is challenging. Utilizing contract service providers has been shown to hasten the patient recruiting process. In order to effectively conduct clinical research, these service providers employ a variety of outreach strategies, such as social media, mobile technologies, electronic health records (EHRs), and real-world evidence (RWE). Over time, they have become increasingly significant in this process. Clinical research is conducted to learn more about the effectiveness and safety of creating new medications and medical equipment. As more people are needed for clinical trials because of regulatory and safety concerns, which are pushing trends toward longer and larger studies, the demand for patient recruiting services is increasing. The global industry has grown significantly as a result of the increasing number of clinical studies and the expanding pharmaceutical and medical industries.

With the increased complexity of clinical trials and the need for specialized patient populations for studies evaluating orphan medications and tailored therapies, several big pharma companies have outsourced their patient recruiting operations, leading to increased clinical trial costs. Delays in product release brought on by sponsors' inability to draw in and keep patients are relatively common and are considered to result in an average loss. The short suspension due to Covid-19 has significantly impacted clinical studies, especially in the area of patient recruiting.

Market Segmentation:

The Patient Recruitment and Retention Services Market is segmented on the basis of Therapeutic Areas, Patient Recruitment Steps, and Trial Phases. Based on Therapeutic Areas, the market is segmented into Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, CNS Disorders, Respiratory Disorders, Hematological Disorders, and Others. Based on Patient Recruitment Steps, the market is segmented into Pre-screening and Screening. Based on Trial Phases, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.

Based on Therapeutic Areas, the oncology segment is accounted as a major contributor to the Patient Recruitment and Retention Services Market

The market for patient recruiting services linked to oncology is predicted to grow at a rapid pace over the forecast period. The upsurge in incidence and prevalence of various cancer disorders, the popularity of advanced therapies (such as biological and targeted pharmacological therapies), and the rising global elderly population are the main factors driving the growth of the oncology/cancer pharmaceuticals market. Additionally, the market for oncology medications is growing due to increased cancer awareness and early cancer detection. During the foreseeable period, profitable opportunities should be available due to the great potential of rising economies and the increased number of potential medications in development. The rate of advancement in cancer treatment is quickening. Emerging from the research and development pipeline are a number of novel therapies that are frequently combined with other brand-new or current medications. Numerous pharmaceutical companies are funding these revolutionary medication development projects for the treatment of cancer.

Based on Trial Phases, the phase III segment is accounted as a major contributor to the Patient Recruitment and Retention Services Market

The phase III category will lead the market in the forecast period with a major revenue share due to the high cost of phase III research. Complicated clinical trials need both clinical resources and potent technology for effective patient recruitment, timely deployment of trial locations, and high-quality study management. The vast majority of pharmaceutical, biopharmaceutical, and medical device companies worldwide use clinical trial service providers to conduct Phase III clinical trials. The market will expand as a result of the several medicines and vaccines that are currently in Phase III and are indicated for the treatment of COVID-19.

In the region, the North America Patient Recruitment and Retention Services Market holds a significant revenue share.

In 2021, North America had the greatest revenue share in the worldwide market. This market is projected to grow given the numerous clinical research being conducted in the region. Government support for clinical trials and significant R&D expenditures are fostering the market's growth. The presence of significant CROs offering support services like patient recruitment and multinational pharmaceutical and biopharmaceutical companies making sizable investments in clinical research have both been credited with the growth of the North American clinical trial patient recruitment services market. The region has become a hub for conducting clinical trials due to the low cost of research, straightforward regulatory compliance, rising patient population, and availability of a few elite clinical institutions functioning as sites.

Competitive Landscape

The key players in the Patient Recruitment and Retention Services Market are Acurian, BBK Worldwide, Bright Pharmaceutical Services, ClinEdge, CSSi, CTM, Evolution Research Group (ERG), Integrated Clinical Trial Services (ICTS), MMG, Veristat, WCCT Global, Antidote, Clinical Accelerator, Fidelis Research, Ignite Data, Polaris BioPharma Consulting, Raremark, Clinrol, CROee, Gitzo Medical Technology, Pacific Grove, and TrialWire.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Patient Recruitment and Retention Services Market Snapshot

Chapter 4. Global Patient Recruitment and Retention Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Therapeutic Areas Estimates & Trend Analysis

5.1. By Therapeutic Areas & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Therapeutic Areas:

5.2.1. Cardiovascular Diseases

5.2.2. Oncological Disorders

5.2.3. Infectious Diseases

5.2.4. CNS Disorders

5.2.5. Respiratory Disorders

5.2.6. Hematological Disorders

5.2.7. Others

Chapter 6. Market Segmentation 2: By Patient Recruitment Steps Estimates & Trend Analysis

6.1. By Patient Recruitment Steps & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Patient Recruitment Steps:

6.2.1. Pre-screening

6.2.2. Screening

Chapter 7. Market Segmentation 3: By Trial Phases Estimates & Trend Analysis

7.1. By Trial Phases & Market Share, 2020 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Trial Phases:

7.2.1. Phase I

7.2.2. Phase II

7.2.3. Phase III

7.2.4. Phase IV

Chapter 8. Patient Recruitment and Retention Services Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2022-2030

8.1.2. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Recruitment Steps, 2022-2030

8.1.3. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by Trial Phases, 2022-2030

8.1.4. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) By Therapeutic Areas, 2022-2030

8.2.2. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) By Patient Recruitment Steps, 2022-2030

8.2.3. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by Trial Phases, 2022-2030

8.2.4. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) By Therapeutic Areas, 2022-2030

8.3.2. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) By Patient Recruitment Steps, 2022-2030

8.3.3. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by Trial Phases, 2022-2030

8.3.4. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2022-2030

8.4. Latin America

8.4.1. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) By Therapeutic Areas, (US$ Million)

8.4.2. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) By Patient Recruitment Steps, (US$ Million)

8.4.3. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by Trial Phases, 2022-2030

8.4.4. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) By Therapeutic Areas, (US$ Million)

8.5.2. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) By Patient Recruitment Steps, (US$ Million)

8.5.3. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by Trial Phases, 2022-2030

8.5.4. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Acurian

9.2.2. BBK Worldwide

9.2.3. Bright Pharmaceutical Services

9.2.4. ClinEdge

9.2.5. CSSi

9.2.6. CTM

9.2.7. Evolution Research Group (ERG)

9.2.8. Integrated Clinical Trial Services (ICTS)

9.2.9. MMG

9.2.10. Veristat

9.2.11. WCCT Global

9.2.12. Antidote

9.2.13. Clinical Accelerator

9.2.14. Fidelis Research

9.2.15. Ignite Data

9.2.16. Polaris BioPharma Consulting

9.2.17. Raremark

9.2.18. Clinrol

9.2.19. CROee

9.2.20. Gitzo Medical Technology

9.2.21. Pacific Grove

9.2.22. TrialWire

9.2.23. Other Prominent Players

Segmentation of Patient Recruitment and Retention Services Market-

By Therapeutic Areas

  • Cardiovascular Diseases
  • Oncological Disorders
  • Infectious Diseases
  • CNS Disorders
  • Respiratory Disorders
  • Hematological Disorders
  • Others

By Patient Recruitment Steps

  • Pre-screening
  • Screening

By Trial Phases

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Patient Recruitment and Retention Services Market?

2021 is valued at 3.63 billion and is predicted to reach 5.45 billion by the year 2031

4.7% CAGR during the projected period.

Our Clients